Table 3.
Adjusted probabilities of outcomes
| GF* | CC+GF* | P | ||
|---|---|---|---|---|
| Non relapse mortality | ||||
| 1–year | 2 (1–4)% | 1 (1–3)% | 0.42 | |
| 2–year | 3 (1–4)% | 2 (1–3)% | 0.32 | |
| 3–year | 3 (1–4)% | 2 (1–4)% | 0.54 | |
| 4–year | 4 (2–6)% | 3 (2–6)% | 0.64 | |
| 5–year | 4 (2–6)% | 3 (2–6)% | 0.64 | |
| Progression-free survival | ||||
| 1–year | 77 (73–81)% | 79 (74–82)% | 0.62 | |
| 2–year | 57 (52–61)% | 62 (57–67)% | 0.13 | |
| 3–year | 43 (38–48)% | 40 (35–45)% | 0.33 | |
| 4–year | 31 (26–37)% | 31 (26–36)% | 0.85 | |
| 5–year | 19 (13–25)% | 26 (20–32)% | 0.11 | |
| Overall survival | ||||
| 1–year | 95 (92–96)% | 92 (89–94)% | 0.10 | |
| 2–year | 88 (84–90)% | 85 (82–89)% | 0.37 | |
| 3–year | 82 (78–86)% | 80 (75–84)% | 0.43 | |
| 4–year | 73 (68–78)% | 71 (65–76)% | 0.54 | |
| 5–year | 62 (54–68)% | 60 (52–67)% | 0.76 | |
Percentage ( 95% confidence interval)